rizatriptan has been researched along with Disease Models, Animal in 6 studies
rizatriptan: structure given in first source; RN given refers to benzoate
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Photophobia was demonstrated using a modified elevated plus maze in which the safe closed arms were brightly illuminated; mutant mice avoided the light despite showing no differences in the standard (anxiety) version of the test." | 1.39 | Behavioral evidence for photophobia and stress-related ipsilateral head pain in transgenic Cacna1a mutant mice. ( Atlin, C; Baran, I; Chanda, ML; Ferrari, MD; Guindi, D; Hathaway, G; Israelian, N; Levenstadt, J; Low, D; Macrae, L; Mariette Lenselink, A; Mogil, JS; O'Shea, L; Silver, A; Spijker, S; Tuttle, AH; van den Maagdenberg, AM; Zendegui, E, 2013) |
| "Rizatriptan therefore has central activity which may contribute to its efficacy against migraine headache." | 1.30 | Rizatriptan has central antinociceptive effects against durally evoked responses. ( Cumberbatch, MJ; Hargreaves, RJ; Hill, RG, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Filla, SA | 1 |
| Winter, MA | 1 |
| Johnson, KW | 1 |
| Bleakman, D | 1 |
| Bell, MG | 1 |
| Bleisch, TJ | 1 |
| Castaño, AM | 1 |
| Clemens-Smith, A | 1 |
| del Prado, M | 1 |
| Dieckman, DK | 1 |
| Dominguez, E | 1 |
| Escribano, A | 1 |
| Ho, KH | 1 |
| Hudziak, KJ | 1 |
| Katofiasc, MA | 1 |
| Martinez-Perez, JA | 1 |
| Mateo, A | 1 |
| Mathes, BM | 1 |
| Mattiuz, EL | 1 |
| Ogden, AM | 1 |
| Phebus, LA | 1 |
| Stack, DR | 1 |
| Stratford, RE | 1 |
| Ornstein, PL | 1 |
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Chanda, ML | 1 |
| Tuttle, AH | 1 |
| Baran, I | 1 |
| Atlin, C | 1 |
| Guindi, D | 1 |
| Hathaway, G | 1 |
| Israelian, N | 1 |
| Levenstadt, J | 1 |
| Low, D | 1 |
| Macrae, L | 1 |
| O'Shea, L | 1 |
| Silver, A | 1 |
| Zendegui, E | 1 |
| Mariette Lenselink, A | 1 |
| Spijker, S | 1 |
| Ferrari, MD | 1 |
| van den Maagdenberg, AM | 1 |
| Mogil, JS | 1 |
| Dong, Z | 1 |
| Jiang, L | 1 |
| Wang, X | 2 |
| Yu, S | 1 |
| Cumberbatch, MJ | 1 |
| Hill, RG | 2 |
| Hargreaves, RJ | 2 |
| Williamson, DJ | 1 |
| Shepheard, SL | 1 |
6 other studies available for rizatriptan and Disease Models, Animal
| Article | Year |
|---|---|
Ethyl (3S,4aR,6S,8aR)-6-(4-ethoxycar- bonylimidazol-1-ylmethyl)decahydroiso-quinoline-3-carboxylic ester: a prodrug of a GluR5 kainate receptor antagonist active in two animal models of acute migraine.
Topics: Acute Disease; Administration, Oral; Animals; Biological Availability; Calcium; Carboxylic Acids; Ce | 2002 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Behavioral evidence for photophobia and stress-related ipsilateral head pain in transgenic Cacna1a mutant mice.
Topics: Analgesics; Animals; Calcium Channels, L-Type; Calcium Channels, N-Type; Disease Models, Animal; Dos | 2013 |
Nociceptive behaviors were induced by electrical stimulation of the dura mater surrounding the superior sagittal sinus in conscious adult rats and reduced by morphine and rizatriptan benzoate.
Topics: Animals; Disease Models, Animal; Dura Mater; Electric Stimulation; Grooming; Male; Morphine; Narcoti | 2011 |
Rizatriptan has central antinociceptive effects against durally evoked responses.
Topics: Action Potentials; Analysis of Variance; Animals; Blood-Brain Barrier; Disease Models, Animal; Dose- | 1997 |
The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation.
Topics: Analysis of Variance; Animals; Blood Proteins; Calcitonin Gene-Related Peptide; Disease Models, Anim | 1997 |